Approval Chart Index of Approved Biosimilars

The Biologics Prescribers Collaborative appreciates FDA’s careful consideration before approving biosimilar applicants. As of December 2018, there are 16 approved biosimilars, with additional approvals expected in the future. This index outlines several key components of biosimilars, including:

  • Proprietary drug name
  • Reference biologic and manufacture
  • Approved indications

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below: